Tema Sinergie
Home   /   Radiotherapy   /   News   /   First European patient to undergo stereotactic radiotherapy breast treatment with GammaPod™

First European patient to undergo stereotactic radiotherapy breast treatment with GammaPod™

22 December 2021

Santa Maria della Misericordia hospital in Udine adopted GammaPod™, a groundbreaking technology specifically designed for breast cancer radiation treatments, for clinical use.

The press conference held on December 23rd 2021 by Azienda sanitaria universitaria Friuli Centrale (ASU FC) made the clinical use of GammaPod™ official. Actually, the first three patients in Europe underwent the radiation treatment with this brand new technology days prior to the official news release.

As of today, the radiotherapy centre at the Santa Maria della Misericordia hospital in Udine is the only European site to have this technology, specifically designed for breast treatments, available; hence, the first centre to offer the clinical advantages of a truly grounbreaking solution.

Udine is the third centre in the world to have GammaPod™ available. The other two are in the United States, home of the company manufacturer of  the system: Xcision Medical Systems, founded by Prof. C. Yu, known as the “father of VMAT”. Such a remarkable detail makes us even more appreciative and proud.

BENEFITS OF RADIOTHERAPY TREATMENTS WITH GAMMAPOD™

The whole set of one-of-a-kind GammaPod™ techniques allow to distribute an awfully precise dose to the target, while dreastically reducing the dose on healthy tissues, skin included. The outstanding features of GammaPod™ grant to enhance clinical results and significantly decrease side effects.

Moreover, in the words of Dr. Marco Trovò – head of the Radiation Oncology Department:

“The unique features of GammaPod™ allow for several benefits, both on the clinical level, and from a social/economic point of view. Among the benefits that patients immediately experience is the time reduction of the overall treatment: instead of the traditional 4-6 weeks, GammaPod easily allows the entire treatment to be administered even in a single day. In our center, thanks to GammaPod, we treated the first patients with 3-5 fractions and then we went directly to the single fraction, to the enormous satisfaction of the patients.”

And Dr. Paolo Scalchi, Head of Health Physics, explains:

GammaPod™ allows to use extreme hypofractionation protocols for its specific features:

1. use of rotating multiple radiation fields

2. prone positioning of the patient with a specific system for stereotactic localization and dislocation of the target in relation to heart and lungs

3. submillimetric accuracy of both irradiation geometry and couch movement.

 

 

The advantages for the patients will include not only a significant decrease of side effects and a much better cosmetic outcome, but also an improvement of their quality of life while undergoing treatment, given a large number of patients are working women.

 

Discover more about Gammapod™

Per maggiori informazioni

Pubblicato in Radioterapia
Tel. +39 0546/622663  Fax. +39 0546/621640
PEC temasinergie@pec.it
Privacy Policy  |  Cookie Policy
© 2024 TEMA SINERGIE S.p.A
Reg. Impr. di RA, C.F., P.IVA, VATn. IT00970310397
Iscr. Reg. Imprese di Ravenna n. 00970310397  |  R.E.A. 111877
RAEE IT08020000002755
Capitale Sociale € 2.000.140,08 int. vers.